Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Recruiting 2Completed 2Withdrawn 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 2Other hematologic neoplasm 2

Conditions

Multiple Myeloma 49Lymphoma, Large B-Cell, Diffuse 15Lymphoma, Follicular 14Lymphoma, B-Cell, Marginal Zone 13Lymphoma 8Recurrence 7Neoplasms 6Lymphoma, Non-Hodgkin 6Lymphoma, Mantle-Cell 5Lymphoma, B-Cell 4Neoplasms, Plasma Cell 3Neoplasm, Residual 3Lymphoma, T-Cell, Peripheral 3Smoldering Multiple Myeloma 2Leukemia, Plasma Cell 2Hematologic Neoplasms 2Waldenstrom Macroglobulinemia 1Vitamin D Deficiency 1Peripheral Nervous System Diseases 1Paraproteinemias 1Leukemia, Myeloid, Acute 1Leukemia, Hairy Cell 1Hodgkin Disease 1Hematologic Diseases 1Heart Failure 1Dendritic Cell Sarcoma, Interdigitating 1Corneal Diseases 1Cardiotoxicity 1Burkitt Lymphoma 1Blood Protein Disorders 1

Interventions

fludarabine 2Lenalidomide 2Dexamethasone 2Cyclophosphamide 2talquetamab 1isatuximab 1idecabtagene vicleucel 1fludarabine phosphate 1Whole-Body Irradiation 1Sirolimus 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Hematopoietic Stem Cell Transplantation 1Budesonide 1Bortezomib 1Allopurinol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Leukemia, Plasma Cell × Lenalidomide × Clear all
NCT05870917 2026-03-02

A Study of VRD-based Regimen Combined With CART-ASCT-CART2 Treatment in Patients With Primary Plasma Cell Leukemia

Institute of Hematology & Blood Diseases Hospital, China

Phase 2 Recruiting
20 enrolled
Other hematologic neoplasmPlasma cell

Leukemia, Plasma Cell

NCT06517017 2025-11-28

UltraFrailMM

University of Utah

Phase 2 Recruiting
40 enrolled
Other hematologic neoplasmPlasma cell

Leukemia, Plasma Cell, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡